TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction

Experimental Eye Research

Volumn 78, Issue 6, 2004, Pages 1155-1162

  Kernacki, Karen A ^a   Chunta, John L ^a   Barrett, Ronald P ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corneal destruction; Pseudomonas aeruginosa; TIMP

Indexed keywords

COLLAGEN TYPE 4; ENZYME ANTIBODY; GELATINASE B; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BASAL CELL; BASEMENT MEMBRANE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; EXPERIMENTAL INFECTION; IMMUNOHISTOCHEMISTRY; INFECTION RESISTANCE; INFECTION SENSITIVITY; KERATITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; STROMA CELL; WESTERN BLOTTING;

ANIMALS; BASEMENT MEMBRANE; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEUTROPHIL ACTIVATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 1942423119     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.12.005     Document Type: Article

References (34)

1. Ashcroft G.S., Herrick S.E., Tarnuzzer R.W., et al. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J. Immunol. 183:1997;169-176.
2. Barletta J.P., Angella G., Balch K., Dimora H.G., Stern G.A., Moser M.T. Inhibition of Pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest. Ophthalmol. Vis. Sci. 37:1996;20-28.
3. Berman M.B., Kenyon K., Hayashi K., L'Hernault N. The pathogenesis of epithelial defects in stromal ulceration. Cavanaugh H.D. The Cornea: Transactions of the World Congress on the Cornea 111. 1988;35-43 Raven, New York.
4. Fini M.E., Girard M.T., Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol. Suppl. 202:1992;26-33.
5. Fini M.E., Parks W.C., Rinehart W.B., et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am. J. Pathol. 65:1996;579-586.
6. Han X., Sun Y., Scott S., Bleich D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes. 50:2001;1047-1055.
7. Hazleman B.L., Watson P.G. Ocular complications of rheumatoid arthritis. Clin. Rheum. Disord. 3:1977;501-526.
8. Hazlett L.D., Rosen D.D., Berk R.S. Age-related susceptibility to Pseudomonas aeruginosa ocular infections in mice. Infect. Immun. 20:1978;25-29.
9. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in corneas of HSV-1 infected mice. J. Immunol. 149:1992;3023-3028.
10. Hyndiuk R.A. Experimental Pseudomonas keratitis. Trans. Am. Ophthalmol. 79:1981;541-624.
11. Kao W., Ebert J., Kao C.W., Covington, Cintron C. Development of monoclonal antibodies recognizing collagenase from rabbit PMN; the presence of this enzyme in ulcerating cornea. Curr. Eye Res. 11:1986;801-811. See also page 815.
12. Kenyon K.R. Inflammatory mechanisms in corneal ulceration. Trans. Am. Ophthalmol. Soc. 83:1985;610-663.
13. Kenyon K.R., Fogle J.A., Stone D.L., Stark W.J. Regeneration of corneal epithelial basement membrane following thermal cauterization. Invest. Ophthalmol. Vis. Sci. 16:1977;292-299.
14. Kernacki K.A., Barrett R., Hazlett L.D. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation. Invest. Ophthalmol. Vis. Sci. 40:1999;3168-3176.
15. Kernacki K.A., Barrett R.P., Hobden J.A., Hazlett L.D. Macrophage inflammatory protein-2 is a mediator polymorphonuclear neutrophil influx in ocular bacterial infection. J. Immunol. 164:2000;1037-1045.
16. Kwon B., Hazlett L.D. Association of CD4+ T-cell dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J. Immunol. 159:1997;6283-6290.
17. Maeda M., Vanlandingham B.D., Ye H., Lu P.C., Azar D.T. Immunoconfocal localization of gelatinase B expressed by migrating intra stromal epithelial cells after deep annular excimer keratectomy. Curr. Eye Res. 17:1998;836-843.
18. Matsubara M., Zieske J.D., Fini M.E. Mechanism of basement dissolution preceding corneal ulceration. Invest. Ophthalmol. Vis. Sci. 32:1991;3221-3237.
19. Matsuda H., Smelser G.K. Epithelium and stroma in alkali-burned corneas. Arch. Ophthalmol. 89:1983;396-404.
20. O'Brien T.P., Li Q.J., Sauerburger F., Reviglio V.E., Rana T., Ashraf M.F. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative dicofenac use. Ophthalmology. 108:2001;656-659.
21. Pahlitzsch T., Sinha P. The alkali-burned cornea: electron microscopical, enzyme histochemical and biochemical observations. Graefs Arch. Clin. Exp. Ophthalmol. 223:1985;278-286.
22. Paterson C.A., Wells J.C., Koklitis P.A., Higgs G.A., Docherty A.J. Recombinant tissue inhibitor of metalloproteinases suppresses alkali-burn-induced corneal ulceration. Invest. Ophthalmol. Vis. Sci. 35:1994;677-684.
23. Pfister R.R., Haddox J.L., Sommers C.I. Effect of a synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst. Invest. Ophthalmol. Vis. Sci. 38:1997;1340-1349.
24. Qin P., Piechocki M., Lu S., Kurpakus M.A. Localization of basement membrane-associated protein isoforms during development of the ocular surface of mouse eye. Dev. Dyn. 209:1997;367-376.
25. Ries C., Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler. 376:1995;345-355.
26. Riley G.P., Harrall R.L., Watson P.G., Cawston T.E., Hazleman B.L. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 9:1995;703-718.
27. Saika S., Kawashima Y., Okada Y., Tanaka S.I., Yamanaka O., Ohnishi Y., Ooshima A. Recombinant TIMP-1 and -2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ. Curr. Eye Res. 17:1998;47-52.
28. Schultz G.S., Strelow S., Stern G.A., et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 33:1992;3325-3331.
29. Seng W.L., Glogowski J.A., Wolf G., Berman M.B., Kenyon K.R., Kiorpes T.C. The effects of thermal burn on the release of collagenase from the cornea. Invest. Ophthalmol. Vis. Sci. 19:1980;1461-1470.
30. Smith V.A., Hoh H.B., Easty D.L. Role of matrix metalloproteinases in peripheral ulcerative keratitis. Br. J. Ophthalmol. 83:1999;1376-1383.
31. Twining S., Wilson P.M., Hatchell D.L. Characterization of corneal proteoglycans under vitamin A deficiency. Biochem. Biophys. Acta. 992:1989;181-190.
32. Wentworth J.S., Patterson C.A., Gray R.D. Effect of a metalloproteinase inhibitor on established corneal ulcers. Invest. Ophthalmol. Vis. Sci. 33:1992;2174-2179.
33. Yan L., Borregard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil associated-lipocalin (NGAL). J. Biol. Chem. 276:2001;37258-37265.
34. Ye H.Q., Azar D.T. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 39:1998;13-921.